NcXHF

BERNARDO H.L. GOULART
lung-cancer/lung-cancer-screening-guidelines/) Accessed January
28, 2015.
6. Bach PB, Gould MK, Silvestri GA. Computed tomography screening for
lung cancer. Ann Intern Med. 2013;159:155-156.
7. Lung Cancer Alliance. CT screening for lung cancer. www.lungcancer
alliance.org/get-information/lung-cancer-online/lung-cancer-overview/
ct-screening.html. Accessed January 28, 2015.
8. Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin.
2014;64:9-29.
9. National Lung Screening Trial Research Team, Aberle DR, Adams AM,
et al. Reduced lung-cancer mortality with low-dose computed tomographic
screening. N Engl J Med. 2011;365:395-409.
10. Ma J, Ward EM, Smith R, et al. Annual number of lung cancer deaths
potentially avertable by screening in the United States. Cancer. 2013;
119:1381-1385.
11. de Koning HJ, Meza R, Plevritis SK, et al. Benefıts and harms of computed
tomography lung cancer screening strategies: a comparative
modeling study for the U.S. Preventive Services Task Force. Ann Intern
Med. 2014;160:311-320.
12. Pyenson BS, Sander MS, Jiang Y, et al. An actuarial analysis shows that
offering lung cancer screening as an insurance benefıt would save lives
at relatively low cost. Health Aff (Millwood). 2012;31:770-779.
13. Pyenson BS, Henschke CI, Yankelevitz DF, et al. Offering lung cancer
screening to high-risk medicare benefıciaries saves lives and is cost-effective:
an actuarial analysis. Am Health Drug Benefıts. 2014;7:272-282.
14. Bach PB. Raising the bar for the U.S. Preventive Services Task Force.
Ann Intern Med. 2014;160:365-366.
15. Miller AB. Screening for lung cancer with low-dose computed tomography.
Oncologist. 2013;18:897-899.
16. Bach PB, Mirkin JN, Oliver TK, et al. Benefıts and harms of CT screening
for lung cancer: a systematic review. JAMA. 2012;307:2418-2429.
17. Phend C. MedPage Today: Medicare advisers say no to lung cancer
screening. www.medpagetoday.com/Pulmonology/LungCancer/
45512. Accessed January 28, 2015.
18. Arenberg D, Kazerooni EA. Setting up a lung cancer screening program.
J Natl Compr Canc Netw. 2012;10:277-285.
19. Ramsey SD, Malin JL, Goulart B, et al. Implementing lung cancer
screening using low-dose computed tomography: recommendations
from an expert panel. J Oncol Pract. Epub 2014 Dec 9.
20. Detterbeck FC, Unger M. Screening for lung cancer: moving into a new
era. Ann Intern Med. 2014;160:363-364.
21. Moyer VA, U.S. Preventive Services Task Force. Screening for lung cancer:
U.S. Preventive Services Task Force recommendation statement.
Ann Intern Med. 2014;160:330-338.
22. Yankelevitz D: Point: should lung cancer screening by chest CT be a
covered benefıt? Yes. Chest. 2015;147:287-289.
23. Centers for Medicare and Medicaid Services. Decision memo for
screening for lung cancer with low dose computed tomography (LDCT)
(CAG-00439N). http://www.cms.gov/medicare-coverage-database/
details/nca-decision-memo.aspx?NCAId274. Accessed March 10,
2015.
24. Roth J, Sullivan S, Ravelo A, et al. Low-dose computed tomography lung
cancer screening in the Medicare program: Projected clinical, resource,
and budget impact. J Clin Oncol. 2014;32:5s (suppl; abstr 6501).
25. Advisory Board Company. Hospitals prepare for boom in lung CT
scans. www.advisory.com/daily-briefıng/2015/01/08/hospitals-preparefor-boom-in-lung-ct-scans.
Accessed January 28, 2015.
26. McMahon PM, Kong CY, Bouzan C, et al. Cost-effectiveness of computed
tomography screening for lung cancer in the United States. J Thorac
Oncol. 2011;6:1841-1848.
27. Goulart BH, Bensink ME, Mummy DG, et al. Lung cancer screening
with low-dose computed tomography: costs, national expenditures, and
cost-effectiveness. J Natl Compr Canc Netw. 2012;10:267-275.
28. Ramsey S, Schickedanz A. How should we defıne value in cancer care?
Oncologist. 2010;15 (suppl):1-4.
29. Gold MR, Siegel JE, Russell LB, et al. Cost-Effectiveness in Health and
Medicine. New York, NY: Oxford University Press; 1996.
30. Marshall D, Simpson KN, Earle CC, et al. Potential cost-effectiveness of
one-time screening for lung cancer (LC) in a high risk cohort. Lung Cancer.
2001;32:227-236.
31. Chirikos TN, Hazelton T, Tockman M, et al. Screening for lung cancer
with CT: a preliminary cost-effectiveness analysis. Chest. 2002;121:
1507-1514.
32. Mahadevia PJ, Fleisher LA, Fric KD, et al. Lung, cancer screening with
helical computed tomography in older adult smokers: a decision and
cost-effectiveness analysis. JAMA. 2003;289:313-322.
33. Wisnivesky JP, Mushlin AI, Sicherman N, et al. The cost-effectiveness of
low-dose CT screening for lung cancer: preliminary results of baseline
screening. Chest. 2003;124:614-621.
34. Villanti AC, Jiang Y, Abrams DB, et al. A cost-utility analysis of lung
cancer screening and the additional benefıts of incorporating smoking
cessation interventions. PLoS One. 2013;8:e71379.
35. Black WC, Gareen IF, Soneji SS, et al. Cost-effectiveness of CT screening
in the National Lung Screening Trial. N Engl J Med. 2014;371:1793-
1802.
36. Oken MM, Hocking WG, Kvale PA, et al. Screening by chest radiograph
and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian
(PLCO) randomized trial. JAMA. 2011;306:1865-1873.
37. Weinstein MC. How much are Americans willing to pay for a qualityadjusted
life year? Med Care 2008;46:343-345.
38. Neumann PJ, Cohen JT, Weinstein MC. Updating Cost-Effectiveness -
The Curious Resilience of the $50,000-per-QALY Threshold. N Engl
J Med. 2014;371:796-797.
39. Cressman S, Lam S, Tammemagi MC, et al. Resource utilization and
costs during the initial years of lung cancer screening with computed
tomography in Canada. J Thorac Oncol. 2014;9:1449-1458.
40. Jonnalagadda S, Bergamo C, Lin JJ, et al. Beliefs and attitudes about lung
cancer screening among smokers. Lung Cancer. 2012;77:526-531.
41. Goulart BH, Ramsey SD. Moving beyond the national lung screening
trial: discussing strategies for implementation of lung cancer screening
programs. Oncologist. 2013;18:941-946.
42. Lewis J, Petty W, Tooze J, et al. Low-dose CT lung cancer screening
practices and attitudes among primary care providers at an academic
medical center. Cancer Epidemiol Biomarkers Prev. Epub 2015 Jan 24.
43. Goulart B, Madtes D, Koepl L, et al. Performance of a low-dose computed
tomography (LDCT) lung cancer screening program: fındings
from a registry study. J Clin Oncol. 2014;32 (suppl 30; abstr 6501).
44. Aberle DR, Henschke CI, McLoud TC, et al. Expert opinion: barriers to
CT screening for lung cancer. J Thorac Imaging. 2012;27:208.
45. Leventhal W. Primary care perspective on lung cancer screening. J Thorac
Imaging. 2012;27:209-210.
46. McKee BJ, McKee AB, Flacke S, et al. Initial experience with a free, highvolume,
low-dose CT lung cancer screening program. J Am Coll Radiol.
2013;10:586-592.
47. Lam VK, Miller M, Dowling L, et al. Community low-dose CT lung cancer
screening: a prospective cohort study. Lung. 2015;193:135-139.
48. Raz DJ, Dunham R, Tiep B, et al. Augmented meaningful use criteria to
identify patients eligible for lung cancer screening. Ann Thorac Surg.
2014;98:996-1002.
49. Tammemägi MC, Katki HA, Hocking WG, et al. Selection criteria for
lung-cancer screening. N Engl J Med. 2013;368:728-736.
50. Volk R. Patient-Centered Outcomes Research Institute: promoting
informed decisions about lung cancer screening. www.pcori.org/
e432
2015 ASCO EDUCATIONAL BOOK | asco.org/edbook